A multidisciplinary team led by scientists at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC Cancer Center, has found that the second-most common type of breast cancer appears to be a good candidate for a personalized approach to treatment. Invasive lobular carcinoma, characterized by a unique growth pattern in breast tissue that fails to form a lump, has distinct genetic markers which indicate drug therapies may provide benefits beyond ...Sunday 6 April 2014
Personalized Treatment Approach may Benefit Patients With Common Breast Cancer Subtype
A multidisciplinary team led by scientists at the University of Pittsburgh Cancer Institute (UPCI), a partner with UPMC Cancer Center, has found that the second-most common type of breast cancer appears to be a good candidate for a personalized approach to treatment. Invasive lobular carcinoma, characterized by a unique growth pattern in breast tissue that fails to form a lump, has distinct genetic markers which indicate drug therapies may provide benefits beyond ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment